Cna Financial Corp Annexon, Inc. Transaction History

Cna Financial Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$2.11 - $4.06 $49,422 - $95,097	-23,423 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$2.73 - $11.94 $10,136 - $44,333	3,713 Added 18.84%	23,423 $64,000
Q4 2021 Feb 11, 2022	BUY	$11.49 - $22.0 $32,057 - $61,380	2,790 Added 16.49%	19,710 $226,000
Q3 2021 Nov 12, 2021	BUY	$16.35 - $23.4 $14,551 - $20,826	890 Added 5.55%	16,920 $315,000
Q2 2021 Aug 12, 2021	BUY	$17.81 - $27.48 $12,288 - $18,961	690 Added 4.5%	16,030 $361,000
Q1 2021 May 14, 2021	BUY	$22.0 - $35.01 $61,380 - $97,677	2,790 Added 22.23%	15,340 $427,000
Q4 2020 Feb 12, 2021	BUY	$20.81 - $30.55 $54,938 - $80,652	2,640 Added 26.64%	12,550 $314,000
Q3 2020 Nov 12, 2020	BUY	$17.5 - $30.23 $173,425 - $299,579	9,910 New	9,910 $300,000

156

101M

3.73M

1.3M

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $335M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

Get notified when there are updates to the investment portfolio of Cna Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Cna Financial Corp with notifications on news.